Literature DB >> 666327

Pyoderma gangrenosum. Abnormal monocyte function corrected in vitro with hydrocortisone.

D A Norris, W L Weston, G Thorne, J R Humbert.   

Abstract

A 34-year-old man with chronic active hepatitis and pyoderma gangrenosum demonstrated abnormalities in neutrophil and monocyte function. Monocytes from this man had diminished chemotaxis and bacterial phagocytosis. These functions were significantly improved in vitro after one hour of incubation of monocytes with 10(-5) hydrocortisone. Neutrophil function was nornal for bactericidal activity and phagocytosis, but neutrophil chemotaxis was diminished. A plasma inhibitor was not found to explain these phagocyte alterations.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666327     DOI: 10.1001/archderm.114.6.906

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  Pyoderma gangrenosum-like skin changes after subcutaneous administration of low molecular weight heparin.

Authors:  Małgorzata Sobieszczańska; Sławomir Tubek; Ilona Kura
Journal:  Hum Vaccin Immunother       Date:  2014-01-17       Impact factor: 3.452

2.  Mononuclear phagocytes and skin diseases.

Authors:  R van Furth; L Hamminga
Journal:  Arch Dermatol Res       Date:  1979-07-30       Impact factor: 3.017

3.  Defective monocyte function in pyoderma gangrenosum with IgG kappa paraproteinaemia.

Authors:  R R Jones; A Kobza Black; M Donaghy; O Moshtael; A J Pinching
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

Review 4.  Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review.

Authors:  Benedetta Terziroli Beretta-Piccoli; Pietro Invernizzi; M Eric Gershwin; Carlo Mainetti
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817

5.  A rare case of adult scalp pyoderma gangrenosum with cranial osteolysis.

Authors:  L Aljohmani; K Abdul-Jalil; C deBlacam; G M Murphy; J B O'Sullivan
Journal:  JPRAS Open       Date:  2018-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.